Abbott Laboratories (ABT) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abbott Laboratories.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:01.793 Good morning and thank you for standing by. 00:00:01.793 -- 00:00:07.280 Welcome to Abbott's second quarter 2025 earnings conference call. 00:00:07.280 -- 00:00:10.764 All participants will be able to listen only until the question and answer portion of 00:00:10.764 -- 00:00:15.951 this call. During the question and answer session, you will be able to ask your question 00:00:15.951 -- 00:00:19.836 by pressing the star one one keys on your touch tone phone. 00:00:19.836 -- 00:00:24.802 This call is being recorded by Abbott. With the exception of any participants questions 00:00:24.802 -- 00:00:29.413 asked during the question and answer session, the entire call including the question 00:00:29.413 -- 00:00:33.419 and answer session, is material copyrighted by Abbott. 00:00:33.419 -- 00:00:38.526 It cannot be recorded or rebroadcast without Abbott's express written permission. 00:00:38.526 -- 00:00:44.652 I would now like to introduce Mr. Mike Camilla, Vice President, Investor Relations. 00:00:46.037 -- 00:00:48.040 Good morning and thank you for joining us. 00:00:48.040 -- 00:00:53.327 With me today are Robert Ford, Chairman and Chief Executive Officer, and Phil Boudreau, 00:00:53.327 -- 00:00:58.013 Executive Vice President, Finance and Chief Financial Officer. 00:00:58.013 -- 00:01:00.717 Robert and Phil will provide opening remarks. 00:01:00.717 -- 00:01:04.242 Following their comments, we'll take your questions. 00:01:04.242 -- 00:01:08.949 Before we get started, some statements made today may be forward looking for purposes 00:01:08.949 -- 00:01:14.397 of the Private Securities Litigation Reform Act of 1995, including 00:01:14.397 -- 00:01:18.359 the expected financial results for 2025. 00:01:19.107 -- 00:01:24.274 Abbott cautio...